FCM
Frontier Capital Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.86M | Sell |
51,801
-19,271
| -27% | -$2.92M | 0.07% | 259 |
|
|
2025
Q1 | $10.7M | Sell |
71,072
-2,143
| -3% | -$323K | 0.12% | 211 |
|
|
2024
Q4 | $13.5M | Sell |
73,215
-133
| -0.2% | -$24.6K | 0.13% | 195 |
|
|
2024
Q3 | $14.4M | Sell |
73,348
-1,033
| -1% | -$203K | 0.14% | 193 |
|
|
2024
Q2 | $15.4M | Buy |
74,381
+6,255
| +9% | +$1.29M | 0.15% | 192 |
|
|
2024
Q1 | $18.5M | Buy |
68,126
+17,003
| +33% | +$4.61M | 0.17% | 170 |
|
|
2023
Q4 | $12.1M | Buy |
51,123
+3,711
| +8% | +$877K | 0.12% | 190 |
|
|
2023
Q3 | $9.29M | Buy |
47,412
+20,076
| +73% | +$3.93M | 0.1% | 197 |
|
|
2023
Q2 | $5.75M | Sell |
27,336
-279
| -1% | -$58.7K | 0.06% | 227 |
|
|
2023
Q1 | $5.57M | Sell |
27,615
-2,492
| -8% | -$503K | 0.06% | 224 |
|
|
2022
Q4 | $6.56M | Buy |
+30,107
| New | +$6.56M | 0.07% | 220 |
|
|
2014
Q2 | – | Sell |
-317
| Closed | -$19K | – | 346 |
|
|
2014
Q1 | $19K | Sell |
317
-891,784
| -100% | -$53.5M | ﹤0.01% | 337 |
|
|
2013
Q4 | $47.3M | Buy |
892,101
+43,521
| +5% | +$2.31M | 0.35% | 101 |
|
|
2013
Q3 | $39.3M | Buy |
848,580
+118,850
| +16% | +$5.5M | 0.3% | 114 |
|
|
2013
Q2 | $29.9M | Buy |
+729,730
| New | +$29.9M | 0.25% | 146 |
|